GlassScriptPhysician profile
Sidney P Rohrscheib
NPI 1073580122
$37,363.90
in general payments reported to CMS, 2019-2025
19 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $5,456 · 2021: $29K · 2022: $146 · 2023: $174 · 2024: $194 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reshape Lifesciences INC. | $29,285.86 | 2019-2023 | |
| Senseonics, Incorporated | $7,255.00 | 2019-2020 | |
| Teleflex LLC | $130.86 | 2023 | Titan Sgs Standard Gastric Stapler |
| Ethicon US, LLC | $119.75 | 2020-2022 | |
| Novo Nordisk INC | $85.85 | 2020-2025 | Wegovy |
| Olympus America INC. | $70.25 | 2022-2025 | Gastrointestinal Videoscope, 4k Cable 3.0m, Olympus |
| Standard Bariatrics, INC. | $65.29 | 2022 | |
| Medtronic, INC. | $57.28 | 2024 | Signia |
| Lilly USA, LLC | $50.60 | 2024-2025 | Zepbound |
| Grifols USA, LLC | $45.54 | 2024-2025 | Gamunex-C |
| Baudax Bio INC. | $38.20 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $33.68 | 2025 | |
| Reprise Biomedical, INC. | $22.85 | 2020 | |
| Averitas Pharma INC. | $22.25 | 2024 | Qutenza |
| Neurocrine Biosciences, INC. | $20.51 | 2023 | Ingrezza, Ongentys |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $18.98 | 2025 | Smartvest |
| Ultragenyx Pharmaceutical INC. | $15.65 | 2024 | Crysvita |
| Teva Pharmaceuticals USA, INC. | $14.19 | 2024 | Austedo Xr |
| W. L. Gore & Associates, INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Rohrscheib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.